145 related articles for article (PubMed ID: 38030566)
1. Receiver operating characteristic curve analysis of the Weiss Functional Impairment Rating Scale-Parent Report for screening children with ADHD: Looking beyond symptoms in ADHD diagnosis.
Kiani B; Hadianfard H; Weiss MD; Dehbozorgi S
Early Interv Psychiatry; 2024 Jun; 18(6):431-438. PubMed ID: 38030566
[TBL] [Abstract][Full Text] [Related]
2. The Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD: evaluating diagnostic accuracy and determining optimal thresholds using ROC analysis.
Thompson T; Lloyd A; Joseph A; Weiss M
Qual Life Res; 2017 Jul; 26(7):1879-1885. PubMed ID: 28220338
[TBL] [Abstract][Full Text] [Related]
3. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
Stein MA; Sikirica V; Weiss MD; Robertson B; Lyne A; Newcorn JH
CNS Drugs; 2015 Nov; 29(11):953-62. PubMed ID: 26547425
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties of the Japanese version of the Weiss Functional Impairment Rating Scale: Self-Report.
Takeda T; Tsuji Y; Kanazawa J; Sakai T; Weiss MD
Atten Defic Hyperact Disord; 2017 Sep; 9(3):169-177. PubMed ID: 28013402
[TBL] [Abstract][Full Text] [Related]
5. Psychometric properties of the Weiss Functional Impairment Rating Scale parent and self-reports in a Norwegian clinical sample of adolescents treated for ADHD.
Haugan AJ; Sund AM; Thomsen PH; Lydersen S; Nøvik TS
Nord J Psychiatry; 2021 Jan; 75(1):63-72. PubMed ID: 32749193
[TBL] [Abstract][Full Text] [Related]
6. Is it possible to determine the level of functional impairment that distinguishes the patients with ADHD from those without ADHD?
Tarakçıoğlu MC; Gökler ME; Kadak MT; Çakın Memik N; Aksoy UM
Qual Life Res; 2019 Apr; 28(4):1097-1103. PubMed ID: 30578453
[TBL] [Abstract][Full Text] [Related]
7. Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Nasser A; Kosheleff AR; Hull JT; Liranso T; Qin P; Busse GD; O'Neal W; Fava M; Faraone SV; Rubin J
J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):214-226. PubMed ID: 33600233
[No Abstract] [Full Text] [Related]
8. Descriptive and psychometric properties of the Persian version of the Weiss functional impairment rating scale: parent report form in Iranian children.
Kiani B; Hadianfard H; Weiss MD
Health Qual Life Outcomes; 2018 Dec; 16(1):225. PubMed ID: 30526625
[TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of a modified version of the Weiss Functional Impairment Rating Scale-Parent Report (WFIRS-P) in a clinical sample of children with aggressive behavior.
Kernder T; Doepfner M; Dose C; Goertz-Dorten A
Qual Life Res; 2019 Jan; 28(1):241-251. PubMed ID: 30276506
[TBL] [Abstract][Full Text] [Related]
10. Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder.
Gajria K; Kosinski M; Sikirica V; Huss M; Livote E; Reilly K; Dittmann RW; Erder MH
Health Qual Life Outcomes; 2015 Nov; 13():184. PubMed ID: 26577642
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Weiss Functional Impairment Rating Scale (WFIRS-P) as a Functional Impairment Measure in a General Population of Schoolchildren.
Arildskov TW; Virring A; Thomsen PH; Lambek R
Assessment; 2023 Dec; 30(8):2533-2544. PubMed ID: 36799215
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Symptomatic and Functional Improvement and Remission in a Treatment Response to Stimulant Trial.
Weiss M; Childress A; Mattingly G; Nordbrock E; Kupper RJ; Adjei AL
J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):521-529. PubMed ID: 30036076
[TBL] [Abstract][Full Text] [Related]
13. Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses.
Coghill DR; Werner-Kiechle T; Farahbakhshian S; Bliss C; Robertson B; Huss M
Eur Child Adolesc Psychiatry; 2021 May; 30(5):809-821. PubMed ID: 32691164
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.
Banaschewski T; Johnson M; Lecendreux M; Zuddas A; Adeyi B; Hodgkins P; Squires LA; Coghill DR
CNS Drugs; 2014 Dec; 28(12):1191-203. PubMed ID: 25139785
[TBL] [Abstract][Full Text] [Related]
15. Turkish validity and reliability study of the Weiss Functional Impairment Rating Scale-Parent Report.
Tarakçıoğlu MC; Memik NÇ; Olgun NN; Aydemir Ö; Weiss MD
Atten Defic Hyperact Disord; 2015 Jun; 7(2):129-39. PubMed ID: 25428590
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder.
Banaschewski T; Soutullo C; Lecendreux M; Johnson M; Zuddas A; Hodgkins P; Adeyi B; Squires LA; Coghill D
CNS Drugs; 2013 Oct; 27(10):829-40. PubMed ID: 23893527
[TBL] [Abstract][Full Text] [Related]
17. Psychometric Properties of the Weiss Functional Impairment Rating Scale: Evidence for Utility in Research, Assessment, and Treatment of ADHD in Emerging Adults.
Canu WH; Hartung CM; Stevens AE; Lefler EK
J Atten Disord; 2020 Oct; 24(12):1648-1660. PubMed ID: 27481918
[No Abstract] [Full Text] [Related]
18. Effect of an Ecological Executive Skill Training Program for School-aged Children with Attention Deficit Hyperactivity Disorder: A Randomized Controlled Clinical Trial.
Qian Y; Chen M; Shuai L; Cao QJ; Yang L; Wang YF
Chin Med J (Engl); 2017 Jul; 130(13):1513-1520. PubMed ID: 28639564
[TBL] [Abstract][Full Text] [Related]
19. Psychometric Properties of the Persian Version of the Weiss Functional Impairment Rating Scale-Self-Report Form in Iranian Adolescents.
Hadianfard H; Kiani B; Weiss MD
J Atten Disord; 2019 Nov; 23(13):1600-1609. PubMed ID: 29099238
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of Conners' Rating Scales-Revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence.
Deb S; Dhaliwal AJ; Roy M
J Intellect Disabil Res; 2008 Nov; 52(11):950-65. PubMed ID: 18179511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
